Business Standard

LeapFrog leads $55 mn investment round in Sequoia-backed MedGenome

This investment will be utilised to expand the clinical genomic testing market by expanding access in Tier-II and Tier-III towns and cities across India

fundraising
Premium

Illustration: Ajay Mohanty

Samreen Ahmad Bengaluru
Sequoia-backed genetic diagnostics company MedGenome raised $55 million in an investment round led by LeapFrog Investments. Existing investors Sofina and Sequoia also participated in the round.

This investment will be utilised to expand the clinical genomic testing market by expanding access in Tier-II and Tier-III towns and cities across India and accelerate the company’s drug discovery programmes.

“Genomics and personalised medicine are the future of healthcare, but emerging markets remain significantly under-penetrated. As the largest player in India in applied genomics, we are well-positioned to fill this gap,” said Sam Santhosh,  CEO and founder of MedGenome.

The Indian genetic diagnostics

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in